Results 81 to 90 of about 5,643,282 (147)
Menstrual disturbances in women with advanced heart failure and heart transplant recipients
BackgroundMenstrual disturbances (MDs) are common among women with advanced heart failure. These disorders can arise from hormonal, hemodynamic, pharmacological, and psychological factors. Heart transplantation (HT) involves changes in the cardiovascular
Noelia Fernández Villa +11 more
doaj +1 more source
A 58-year-old man with chronic nonischemic cardiomyopathy and nonalcoholic cirrhosis awaiting dual-organ transplantation was admitted for acute anemia. Esophagogastroduodenoscopy and colonoscopy were performed, revealing grade II esophageal varices and ...
Shriya Sharma +3 more
doaj +1 more source
Background: The sinus node inhibitor ivabradine was approved for patients with heart failure (HF) after the ivabradine and outcomes in chronic HF (SHIFT [Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial ...
Das, D. +26 more
core +1 more source
Background Right ventricular (RV) myocardial work (RVMW) recently emerged as a non‐invasive alternative for the assessment of RV contractility. However, none of the prior studies assessed its variations under different haemodynamic conditions.
Paolo Manca +12 more
doaj +1 more source
Background - The pathogenic role of ischemic heart disease (IHD) in heart failure (HF) with reduced ejection fraction (HFrEF; EF
Lam, Carolyn S P +44 more
core +1 more source
Aldosterone antagonism in heart failure
Alan B MillerDivision of Cardiology, University of Florida/Jacksonville, FL, USAAbstract: Aldosterone, a neurohormone known to affect electrolytes, has recently been implicated as playing a major role in the progression of heart failure, particularly in ...
Alan B Miller
core
Inotropes do not increase mortality in advanced heart failure
Maya Guglin, Marc KaufmanUniversity of South Florida, Tampa, FL, USAAbstract: Inotrope use is one of the most controversial topics in the management of heart failure.
Kaufman M, Guglin M
core
Better Is the Enemy of Good: Ever-changing Heart Transplant Allocation
David A. Baran, MD, FACC, FSCAI, FHFSA
doaj +1 more source

